Eric Lefkofsky: The Great Man Behind Tempus
Eric Lefkofsky is a renowned technology expert and philanthropist in Chicago. He is the Chief Executive Officer and founding partner at Tempus. He also co-founded Lightbank which funds businesses in disruptive technology. Lefkofsky is also the co-founder and Chair of a worldwide e-commerce marketplace, Groupon. He serves in other organizations at both leadership and managerial positions. Additionally, he is the co-chairman of the Lefkofsky Family Foundation, a high-impact initiative he founded together with his wife in a bid to enhance lives at the community level.Since the launch of Tempus Labs in 2006, Eric has been actively involved in enhancing its growth and sustainability.
Tempus provides quality services in genomic sequencing with a major goal of helping physicians in making comprehensive treatment decisions for their cancer patients. It primarily deals with the collection and analysis of clinical as well as molecular data from different cancer centers and hospitals around the country. Tempus partners with other companies including the Clinical Oncology of the American Society, Mayo Clinic, and the Northwestern University’s Lurie Comprehensive Cancer Center among others. Tempus currently stands at more than one billion dollars value. It is committed to ensuring the well-being of cancer patients.
Eric Lefkofsky’s career borrows heavily from his education background. He holds a J.D and a Bachelor’s degree from the University of Michigan.Eric is the chairperson to the Steppenwolf Theatre trustees’ board. Additionally, he is a dedicated trustee at the Chicago Art Institute. He is also a member of the Chicago-based Lurie Children’s Hospital. Besides the Lefkofsky Family Foundation, the Lefkofsky’s signed the giving pledge by Bill Gates and Warren Buffett; where half of their wealth goes to charity. In his efforts to help the cancer situation, Eric seeks to play a vital role in enhancing cancer treatment and other dreadful diseases by using precision medicine. He wishes to save at least 100,000 lives every year within the next decade.